- Recent Funding
- Investors
- AimedBio
AimedBio portfolio
AimedBio has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Inocras's $31M Series B+ round in August 2026, which it led, alongside Dt& Investment, Korea Investment & Securities, Woori Investment Bank and 6 others. That company is in Health and bio.
What AimedBio invests in
- Health and bio · 1 · 100%
- Data and analytics · 1 · 100%
How AimedBio invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $31M |
AimedBio portfolio companies
| Company | Round with AimedBio | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $31M · lead | $31M | Aug 3, 2026 Series B+ |
Most frequent co-investors
DDSC Investment1 shared round · last Aug 3, 2026
IIMM Investment1 shared round · last Aug 3, 2026
DDt& Investment1 shared round · last Aug 3, 2026
KKorea Investment & Securities1 shared round · last Aug 3, 2026
WWoori Investment Bank1 shared round · last Aug 3, 2026
NNational Diversified Sales1 shared round · last Aug 3, 2026
SShinhan Investment1 shared round · last Aug 3, 2026
Lloftyrock investment1 shared round · last Aug 3, 2026
DDunamu & Partners1 shared round · last Aug 3, 2026
Similar investors
CCove Hill Partners1 company
SSomersault Ventures2 companies · 1 deal in 12 mo
SSequoia Capital Global Equities4 companies
AAraya Ventures5 companies · 4 deals in 12 moCCervin Ventures5 companies · 3 deals in 12 mo
FFifth Down Capital6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name AimedBio. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists AimedBio, which is a subset of its real portfolio. API: /api/v1/investors/aimedbio (get a free API key). More: the most active VC firms and new venture capital funds.